Avantor, Inc. (AVTR)
14.26
-0.20
(-1.38%)
USD |
NYSE |
Aug 24, 16:00
Avantor Net Income (Quarterly) : 38.10M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.10M |
| March 31, 2026 | 43.30M |
| December 31, 2025 | 52.40M |
| September 30, 2025 | -711.80M |
| June 30, 2025 | 64.70M |
| March 31, 2025 | 64.50M |
| December 31, 2024 | 500.40M |
| September 30, 2024 | 57.80M |
| June 30, 2024 | 92.90M |
| March 31, 2024 | 60.40M |
| December 31, 2023 | 98.50M |
| September 30, 2023 | 108.40M |
| June 30, 2023 | -7.30M |
| March 31, 2023 | 121.50M |
| December 31, 2022 | 141.70M |
| September 30, 2022 | 167.00M |
| June 30, 2022 | 187.40M |
| March 31, 2022 | 190.40M |
| Date | Value |
|---|---|
| December 31, 2021 | 94.00M |
| September 30, 2021 | 156.80M |
| June 30, 2021 | 157.80M |
| March 31, 2021 | 164.00M |
| December 31, 2020 | 51.60M |
| September 30, 2020 | -42.20M |
| June 30, 2020 | 60.20M |
| March 31, 2020 | 47.00M |
| December 31, 2019 | 70.60M |
| September 30, 2019 | 22.10M |
| June 30, 2019 | -48.70M |
| March 31, 2019 | -6.20M |
| December 31, 2018 | -53.30M |
| September 30, 2018 | 34.50M |
| June 30, 2018 | -26.90M |
| March 31, 2018 | -41.20M |
| December 31, 2017 | -125.40M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 121.36M |
| Champions Oncology, Inc. | -0.667M |
| Personalis, Inc. | -31.68M |
| Adaptive Biotechnologies Corp. | -39.94M |
| 10X Genomics, Inc. | -17.93M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.692B |
| Total Expenses (Quarterly) | 1.654B |
| EPS Diluted (Quarterly) | 0.0563 |
| Enterprise Value | 13.04B |
| Gross Profit Margin (Quarterly) | 31.73% |
| Profit Margin (Quarterly) | 2.25% |
| Earnings Yield | -5.94% |
| Operating Earnings Yield | 5.56% |
| Normalized Earnings Yield | 0.0589 |